Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

SHBG may be a useful early indicator and treatment target for PCOS.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride affects prostate weights and pituitary activity differently with age.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.